Brief: Mabion Signs About 2 Mln Zloty Deal With WPD Pharmaceuticals
17/04/2025 17:12
April 17 (Reuters) - Mabion SA MABP.WA: SIGNS AGREEMENT WITH WPD PHARMACEUTICALS FOR ANALYTICAL METHOD DEVELOPMENT DEAL VALUE SET AT ABOUT PLN 2.0 MILLION NET Source text: ID:nEM8nr1RWa Further company coverage: MABP.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on WPD Pharmaceuticals
See all newsBrief: Mabion Signs LoI With WPD Pharmaceuticals On Extension Of Cooperation
Brief: Mabion Signs About 2 Mln Zloty Deal With WPD Pharmaceuticals
Brief: WPD Pharmaceuticals Signs Annex To License Agreement With Wake Forest University Health Sciences
Brief: WPD Pharmaceuticals Announces Proposed Restructuring Of Polish Subsidiary
Brief: WPD Pharmaceuticals Enters Into Amended And Restated Sublicense Agreement With Moleculin Biotech